deltatrials
Active Not Recruiting INTERVENTIONAL NCT03034811

Persona Partial Knee Clinical Outcomes Study

Sponsor: Zimmer Biomet

Updated 21 times since 2017 Last updated: Apr 17, 2026 Started: Feb 8, 2017 Primary completion: Sep 1, 2030 Completion: Sep 1, 2030
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03034811, this observational or N/A phase trial focuses on Avascular Necrosis and Conditional Revision of the Articular Surface and remains ongoing. Sponsored by Zimmer Biomet, it has been updated 21 times since 2017, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Study Description(click to expand)

The study design is a prospective, multicenter, noncontrolled study of the commercially available Persona Partial Knee. The study will require each site to obtain IRB approval prior to study enrollment. All potential study subjects will be required to participate in the Informed Consent Process. All study subjects will undergo preoperative clinical evaluations prior to their partial knee arthroplasty. Investigators will collect clinical data for a required 2 years with the option to continue follow-up assessment up to 10 years. Follow-up clinical visits include 3 months, 1 year, 2, 5, and 10 years post-operatively. The primary objective of this study is to obtain implant survivorship and clinical outcomes data for the commercially available Persona Partial Knee System. The assessments will include: implant survivorship based on revision with removal of the study device; safety based on incidence and frequency of adverse events; and clinical performance measured by overall pain and function, quality of life data, radiographic parameters, and survivorship.

The study design is a prospective, multicenter, noncontrolled study of the commercially available Persona Partial Knee. The study will require each site to obtain IRB approval prior to study enrollment. All potential study subjects will be required to participate in the Informed Consent Process.

All study subjects will undergo preoperative clinical evaluations prior to their partial knee arthroplasty. Investigators will collect clinical data for a required 2 years with the option to continue follow-up assessment up to 10 years. Follow-up clinical visits include 3 months, 1 year, 2, 5, and 10 years post-operatively.

The primary objective of this study is to obtain implant survivorship and clinical outcomes data for the commercially available Persona Partial Knee System. The assessments will include: implant survivorship based on revision with removal of the study device; safety based on incidence and frequency of adverse events; and clinical performance measured by overall pain and function, quality of life data, radiographic parameters, and survivorship.

Status Flow

~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~Jul 2017 · 3 months · monthly snapshot~Jul 2017 – ~Jun 2018 · 11 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Oct 2018 · 3 months · monthly snapshot~Oct 2018 – ~Jun 2019 · 8 months · monthly snapshot~Jun 2019 – ~Feb 2020 · 8 months · monthly snapshot~Feb 2020 – ~Sep 2020 · 7 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~May 2022 · 13 months · monthly snapshot~May 2022 – ~May 2023 · 12 months · monthly snapshot~May 2023 – ~Sep 2023 · 4 months · monthly snapshot~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Jan 2025 · 2 months · monthly snapshot~Jan 2025 – ~Mar 2025 · 59 days · monthly snapshot~Mar 2025 – ~Sep 2025 · 6 months · monthly snapshot~Sep 2025 – ~Apr 2026 · 8 months · monthly snapshotApr 23, 2026 – present · 27 days · daily API

Change History

21 versions recorded
  1. Apr 23, 2026 — Present [daily]

    Active Not Recruiting

    Phase: NANone

  2. Sep 2025 — Apr 2026 [monthly]

    Active Not Recruiting NA

  3. Mar 2025 — Sep 2025 [monthly]

    Active Not Recruiting NA

  4. Jan 2025 — Mar 2025 [monthly]

    Active Not Recruiting NA

  5. Nov 2024 — Jan 2025 [monthly]

    Active Not Recruiting NA

Show 16 earlier versions
  1. Sep 2024 — Nov 2024 [monthly]

    Active Not Recruiting NA

  2. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting NA

  3. Sep 2023 — Jul 2024 [monthly]

    Active Not Recruiting NA

  4. May 2023 — Sep 2023 [monthly]

    Active Not Recruiting NA

  5. May 2022 — May 2023 [monthly]

    Active Not Recruiting NA

  6. Apr 2021 — May 2022 [monthly]

    Active Not Recruiting NA

  7. Jan 2021 — Apr 2021 [monthly]

    Active Not Recruiting NA

  8. Sep 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  9. Feb 2020 — Sep 2020 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  10. Jun 2019 — Feb 2020 [monthly]

    Recruiting NA

  11. Oct 2018 — Jun 2019 [monthly]

    Recruiting NA

  12. Jul 2018 — Oct 2018 [monthly]

    Recruiting NA

  13. Jun 2018 — Jul 2018 [monthly]

    Recruiting NA

  14. Jul 2017 — Jun 2018 [monthly]

    Recruiting NA

  15. Apr 2017 — Jul 2017 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  16. Feb 2017 — Apr 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

The primary objective of this study is to obtain implant survivorship and clinical outcomes data for the commercially available Persona Partial Knee System.

Contact Information

Sponsor contact:
  • Zimmer Biomet
Data source: ClinicalTrials.gov

For direct contact, visit the study record on ClinicalTrials.gov .